Prostacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in children.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1953009.
- Also identified by PMC identifier 1793527.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The role of prostacyclin in the pathogenesis of haemolytic uraemic syndrome was evaluated in 11 children with acute shigellosis. Plasma concentrations of 6-keto prostaglandin, F1 alpha, a stable metabolite of prostacyclin, were measured by radioimmunoassay during acute illness, early convalescence, and after clinical recovery. Its concentration was low during acute illness in each patient, returning to normal concentrations or above at the time of the last sample. These results suggest that plasma prostacyclin may be involved in the development of the syndrome.
Medical subject headings
- Dysentery, Bacillary
- Epoprostenol
- Hemolytic-Uremic Syndrome